BCBS Settlement Checks Are Arriving: Are Yours Plan Assets?
More than a decade after filing, the $2.67 billion Blue Cross Blue Shield subscriber antitrust settlement is finally paying out. According to Becker's Payer Issues, the initial distribution of payments to valid claimants began rolling out May 11, 2026, closing a chapter that opened with litigation in 2012 and a settlement reached in October 2020.
For the individuals and employers covered by a Blue plan between 2008 and 2020, the checks and prepaid cards now landing are welcome news. But for self-funded plan sponsors and benefits committees, the arrival of settlement money raises a question most carriers and TPAs will not raise for them: when a recovery flows from premiums or claims the plan itself paid, is that money a plan asset? Under ERISA, the answer determines who may keep it, how it must be used, and whether a fiduciary breach is in play. The payout is a news event. Stewardship of the proceeds is a fiduciary duty.
What the $2.67B BCBS Settlement Is, and Why It Is Paying Out Now
The litigation began in 2012 when health plan members filed a class-action antitrust suit against the Blue Cross Blue Shield Association and its affiliates. The plaintiffs alleged that the Blue plans conspired to divide geographic markets and avoid competing with one another, driving up consumer costs. BCBS denied all allegations of wrongdoing, and the court never ruled on the merits.
The case, In re: Blue Cross Blue Shield Antitrust Litigation (MDL 2406, N.D. Ala.), settled in October 2020 for $2.67 billion, with BCBS admitting no wrongdoing. The class covered individuals and employers with Blue coverage between 2008 and 2020. A federal judge in Alabama gave final approval in August 2022; the 11th U.S. Circuit Court of Appeals upheld it in 2023; and the U.S. Supreme Court declined to hear a challenge from Home Depot in 2024. With appeals exhausted, the claims administrator confirmed the initial distribution to valid claimants began May 11, 2026.
One detail in the official settlement record matters enormously for plan sponsors and is easy to miss: the deadlines have already passed. The claim-filing deadline was November 5, 2021, and the opt-out and objection deadline for self-funded entity accounts was May 2, 2022. The settlement's own FAQ states the consequence plainly for anyone who took no action: you remain bound by the settlement, and if you were entitled to share in the proceeds, you will not get a payment.
If you did nothing, you are bound by the settlement, and if you were entitled to a payment, you will not receive one. Procedural inaction is not a neutral act for a fiduciary.
The Fiduciary Question: Are Settlement Proceeds Plan Assets?
For an ERISA-governed self-funded plan, a settlement check is not simply corporate income. When a recovery is attributable to amounts the plan paid, premiums, administrative fees, or claims funded with plan money, a portion of those proceeds may constitute plan assets. Plan assets are governed by ERISA's exclusive benefit rule: they must be used for the exclusive benefit of plan participants and beneficiaries, or to defray the plan's reasonable administrative expenses.
The Department of Labor has not issued guidance specific to the BCBS settlement. Absent that, benefits counsel analyzing settlements like this one commonly point to the DOL's established medical loss ratio (MLR) rebate framework as the closest analog for estimating which share of a recovery is plan assets and how those funds may be used, though the specific methodology for any given plan is a question for the plan's own ERISA counsel.
What Prudence Looks Like in Practice
Determine the plan-asset share. Estimate the portion of any BCBS recovery attributable to plan contributions versus employer contributions, using a reasonable, documentable methodology.
Use the plan-asset share for participants. Apply for the exclusive benefit of participants, for example to offset premiums, fund benefit enhancements, or defray reasonable plan expenses, not to general corporate accounts.
Document the decision. Record the methodology, the allocation, and the committee's reasoning. Prudence documentation is the evidence that defends the decision if it is ever questioned.
Confirm receipt and accuracy. For plans that filed, verify the payment actually arrived and reconcile it against the coverage period and contributions claimed.
None of these steps is exotic. They are the ordinary discipline ERISA expects whenever plan money moves. The risk is not that the rules are unclear. It is that a settlement payout looks like a windfall and gets treated like one.
Who Controls Recovery, and the Cost of Letting the Carrier Decide
The BCBS payout lands at the same moment another fiduciary fault line is widening: who holds the authority to pursue, settle, or opt a plan out of class actions in the first place. When that authority sits with a carrier or TPA rather than the plan fiduciary, a party whose interests don't align with participants can make the plan's recovery decisions.
Recoveries attributable to plan-paid claims belong to the plan, not the administrator, yet administrators increasingly seek contractual language authorizing them to make those calls, sometimes retroactively and sometimes while taking a percentage of the recovery. A fiduciary decision cannot be converted into a routine vendor task simply by inserting authorizing language into a service agreement. The BCBS timeline shows why this matters: the windows to file and to opt out are real, dated, and unforgiving, and once they close, the plan's rights are fixed.
If the carrier or TPA controls the recovery | If the fiduciary retains control |
Opt-out and settlement decisions may be made without the plan's informed input | The plan makes its own informed decision on filing, opting out, or objecting |
A percentage of the recovery may be retained as an administrative fee | The full plan-asset share flows to the plan and its participants |
No independent record that the decision served participants | A documented, defensible record of prudent process |
Missed deadlines surface only after the right is already lost | Deadlines are tracked as part of ongoing fiduciary oversight |
A settlement payout looks like a windfall. For a self-funded plan, a portion of it is participant money, and ERISA treats it accordingly.
Beyond the Payout: The “Second Blue Bid” and Antitrust Exposure That Hasn't Ended
The settlement did more than create a fund. As Becker's reported, it required BCBS companies to eliminate two association rules: one mandating that two-thirds of national net revenue come from Blue-branded products, and one forcing large employers to work with the Blue insurer covering their headquarters' geography. Instead, the settlement created the “second blue bid,” a mechanism that lets certain large employers solicit bids from any BCBS plan in the country.
That structural change is already reshaping the market. Elevance Health, which operates Anthem BCBS plans in 14 states, said in January that it bid on 11 national accounts in competing BCBS markets in 2025 and won nine. For large self-funded employers, the second blue bid is a procurement opportunity with a fiduciary dimension: the duty of prudence supports testing the market and documenting why the chosen arrangement serves participants, not simply renewing by default.
And the antitrust story is far from over. A separate $2.8 billion provider settlement, the largest of its kind in healthcare, was approved in August 2025, yet nearly 6,500 providers, including facilities owned by Mayo Clinic, Providence, University of Michigan Health, and AdventHealth, opted out. In February 2026, physician staffing groups filed a new federal antitrust suit in California, alleging ongoing market allocation, reimbursement suppression, and price fixing. The competitive dynamics that produced this litigation remain unresolved.
The ClaimInformatics Perspective: Independent Oversight Turns a Payout Into Prudence
A settlement check is a one-time event. The fiduciary duty it exposes, to know what the plan paid, recover what belongs to participants, and document every decision, is continuous.
100% independent. ClaimInformatics holds no ownership, revenue-sharing, or contractual ties to carriers, TPAs, or networks. The plan's fiduciary makes recovery decisions, informed by an analysis with no conflict of interest.
100% claims review, not a ~1% sampling. Independent review of every claim, rather than the industry-standard statistical sampling, surfaces overpayments and patterns that ordinary spot checks miss, restoring plan assets that would otherwise be lost.
Provider friendly recovery. When overpayments are identified, we pursue recovery through a measured, provider friendly process designed to restore plan assets without unnecessary friction.
Review-ready documentation. Every finding includes a transparent rationale, the documentation of prudence a benefits committee needs to demonstrate compliance with ERISA, CAA, and the No Surprises Act.
The BCBS payout is a useful prompt: it asks every self-funded fiduciary whether they actually know what their plan paid, what it is owed, and who is making decisions about the plan's money. Independent oversight is how that question gets a confident answer.
Is a settlement payout sitting in the wrong account? ClaimInformatics provides independent, conflict-free claims oversight that helps self-funded fiduciaries identify and restore plan assets, document prudence, and keep recovery decisions where ERISA expects them: with the plan. Schedule a confidential assessment: claiminformatics.com/contact or send an email to hello@claiminformatics.com for immediate follow-up. |
FAQs Block
Are BCBS antitrust settlement proceeds plan assets under ERISA?
They can be, in part. When a recovery is attributable to amounts the plan paid, such as premiums or claims funded with plan money, that portion is generally treated as a plan asset and must be used for the exclusive benefit of participants or to defray reasonable plan expenses. Absent DOL guidance specific to this settlement, advisors commonly reference the DOL's MLR-rebate framework as an analog for estimating the plan-asset share. This is a question for the plan's ERISA counsel.
Can our company still file a claim for the BCBS settlement?
No. According to the official settlement record, the deadline to file a claim was November 5, 2021, and the opt-out and objection deadline for self-funded entity accounts was May 2, 2022. Both have passed. Plans that filed valid claims are now receiving distributions; plans that took no action are bound by the settlement and will not receive a payment.
What is the “second blue bid,” and does it affect self-funded employers?
The settlement eliminated an association rule that required large employers to use the Blue plan covering their headquarters' geography. The “second blue bid” now lets certain large employers solicit bids from any BCBS plan nationally. For large self-funded employers, that creates a real procurement opportunity, and a prudent fiduciary documents why the resulting arrangement serves participants.
Who should decide whether to pursue or opt out of a class-action recovery for our plan?
For an ERISA plan, decisions about pursuing, settling, or opting out of litigation that affects plan assets are fiduciary decisions. They should rest with the plan's fiduciary, not be delegated by default to a carrier or TPA whose interests may differ, particularly where the administrator would retain a percentage of any recovery.
How does independent claims oversight relate to the BCBS settlement?
The settlement reminds us that the plan can recover money it paid, and that recovering and properly allocating it is a fiduciary responsibility. Independent, conflict-free claims review identifies overpayments through 100% review rather than sampling, restores plan assets, and produces documentation that demonstrates prudent oversight.
The Bottom Line
The $2.67 billion BCBS payout closes a 14 year legal saga, but for self-funded plan sponsors, it opens a fiduciary one. A portion of any recovery attributable to plan-paid amounts is plan assets, governed by ERISA's exclusive benefit rule, and the decisions around it, allocation, use, and who controls the plan's recovery rights, are fiduciary decisions that deserve a documented, conflict-free process. The carriers will not raise these questions. A prudent fiduciary does.
Has your benefits committee decided how it will treat a BCBS settlement distribution? Share your approach in the comments.
Related Resources from ClaimInformatics
Verified Sources
Source | Detail | Status |
Becker's Payer Issues (Jakob Emerson, May 19, 2026) | Settlement timeline, payout start date, Second Blue Bid, Elevance figures, $2.8B provider settlement, Feb 2026 suit | Verified |
Official BCBS Settlement website (bcbssettlement.com) | Final approval date (Aug 9, 2022); claim and opt-out/objection deadlines | Verified |
DOL EBSA | ERISA exclusive benefit rule; plan-asset principles | Verified |
Source links: Becker's Payer Issues | Official settlement site | DOL EBSA
This article is provided for educational purposes and does not constitute legal advice. Plan sponsors should consult qualified ERISA counsel regarding the treatment of any settlement proceeds. ClaimInformatics is not affiliated with Becker's Healthcare, the Blue Cross Blue Shield Association, or the settlement administrator.




Comments